These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18202775)

  • 1. Fungal metabolites modulating NF-kappaB activity: an approach to cancer therapy and chemoprevention (review).
    Petrova RD; Reznick AZ; Wasser SP; Denchev CM; Nevo E; Mahajna J
    Oncol Rep; 2008 Feb; 19(2):299-308. PubMed ID: 18202775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
    Zhang Z; Rigas B
    Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear factor-kappaB activation: from bench to bedside.
    Sethi G; Sung B; Aggarwal BB
    Exp Biol Med (Maywood); 2008 Jan; 233(1):21-31. PubMed ID: 18156302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models.
    Kwon KH; Barve A; Yu S; Huang MT; Kong AN
    Acta Pharmacol Sin; 2007 Sep; 28(9):1409-21. PubMed ID: 17723174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
    Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marine natural products as targeted modulators of the transcription factor NF-kappaB.
    Folmer F; Jaspars M; Dicato M; Diederich M
    Biochem Pharmacol; 2008 Feb; 75(3):603-17. PubMed ID: 17919455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of chemoprevention by resveratrol: NF-kappaB and AP-1 as potential targets.
    Kundu JK; Surh YJ
    Mutat Res; 2004 Nov; 555(1-2):65-80. PubMed ID: 15476852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways.
    Ramos S
    Mol Nutr Food Res; 2008 May; 52(5):507-26. PubMed ID: 18435439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting specific cell signaling transduction pathways by dietary and medicinal phytochemicals in cancer chemoprevention.
    Neergheen VS; Bahorun T; Taylor EW; Jen LS; Aruoma OI
    Toxicology; 2010 Dec; 278(2):229-41. PubMed ID: 19850100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
    Sarkar FH; Li Y; Wang Z; Kong D
    Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy.
    Holcomb B; Yip-Schneider M; Schmidt CM
    Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
    Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
    Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 and epidermal growth factor receptor: pharmacologic targets for chemoprevention.
    Dannenberg AJ; Lippman SM; Mann JR; Subbaramaiah K; DuBois RN
    J Clin Oncol; 2005 Jan; 23(2):254-66. PubMed ID: 15637389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals.
    Kundu JK; Surh YJ
    Mutat Res; 2005 Dec; 591(1-2):123-46. PubMed ID: 16102784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-kappa B and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities.
    Surh YJ
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():269-72. PubMed ID: 18296353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
    Wong ET; Tergaonkar V
    Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using NF-κB as a molecular target for theranostics in radiation oncology research.
    Liu YC; Chiang IT; Hsu FT; Hwang JJ
    Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6,7-dihydroxy-3,4-dihydroisoquinoline: a novel inhibitor of nuclear factor-kappaB and in vitro invasion in murine mammary cancer cells.
    Alvarez FN; Carlson LM; Lindner I; Lee KP
    Chemotherapy; 2009; 55(3):175-82. PubMed ID: 19407445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New insights on the anticancer properties of dietary polyphenols.
    Fresco P; Borges F; Diniz C; Marques MP
    Med Res Rev; 2006 Nov; 26(6):747-66. PubMed ID: 16710860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.